BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 2, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 22, 2007
View Archived Issues
Other News To Note
Read More
Appointments And Advancements
Read More
TransTech Acquires Entire GKA Program In Diabetes From Novo
TransTech Pharma Inc. reacquired all rights to a glucokinase activator program that it had partnered with Novo Nordisk A/S more than five years ago, increasing an already healthy pipeline in the area of diabetes. (BioWorld Today)
Read More
FDA Decides Against Reviewing Pharmacyclics' NDA For Xcytrin
Read More
Dyax Regains All DX-88 Rights, $17M; Ends JV With Genzyme
Read More
CoDa Raises $20M Series A For Wound Healer Nexagon
Read More
Access Adding Cancer Products Though Acquisition Of Somanta
Read More
Clinic Roundup
Read More